Related Experiment Video
Updated: Apr 25, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
Stem cell based gene therapy in prostate cancer
Jae Heon Kim1, Hong Jun Lee2, Yun Seob Song1
1Department of Urology, Soonchunhyang University, College of Medicine, Soonchunyang University Hospital, Seoul 140-743, Republic of Korea.
Abstract:
Current prostate cancer treatment, especially hormone refractory cancer, may create profound iatrogenic outcomes because of the adverse effects of cytotoxic agents. Suicide gene therapy has been investigated for the substitute modality for current chemotherapy because it enables the treatment targeting the cancer cells. However the classic suicide gene therapy has several profound side effects, including immune-compromised due to viral vector. Recently, stem cells have been regarded as a new upgraded cellular vehicle or vector because of its homing effects. Suicide gene therapy using genetically engineered mesenchymal stem cells or neural stem cells has the advantage of being safe, because prodrug administration not only eliminates tumor cells but consequently kills the more resistant therapeutic stem cells as well. The attractiveness of prodrug cancer gene therapy by stem cells targeted to tumors lies in activating the prodrug directly within the tumor mass, thus avoiding systemic toxicity. Therapeutic achievements using stem cells in prostate cancer include the cytosine deaminase/5-fluorocytosine prodrug system, herpes simplex virus thymidine kinase/ganciclovir, carboxyl esterase/CPT11, and interferon-beta. The aim of this study is to review the stem cell therapy in prostate cancer including its proven mechanisms and also limitations.
Insights
Stem cell-based suicide gene therapy offers a safer alternative to traditional prostate cancer treatments by targeting cancer cells and minimizing systemic toxicity. This approach utilizes genetically engineered stem cells to deliver therapeutic agents directly to tumors.
Area of Science:
- Oncology
- Gene Therapy
- Stem Cell Biology
Background:
- Current prostate cancer treatments, particularly for hormone-refractory cases, often involve cytotoxic agents with significant adverse effects.
- Classic suicide gene therapy, while targeting cancer cells, can cause immune compromise due to viral vectors.
Purpose of the Study:
- To review the mechanisms and limitations of stem cell-based suicide gene therapy for prostate cancer.
- To explore stem cells as advanced cellular vectors for targeted cancer treatment.
Main Methods:
- Review of existing literature on stem cell-mediated gene therapy for prostate cancer.
- Analysis of various prodrug systems employed with stem cells, including cytosine deaminase/5-fluorocytosine and herpes simplex virus thymidine kinase/ganciclovir.
Main Results:
- Stem cells, particularly mesenchymal and neural stem cells, exhibit homing effects beneficial for targeted cancer therapy.
- Stem cell-based suicide gene therapy activates prodrugs within the tumor mass, reducing systemic toxicity and potentially eliminating resistant cancer cells and therapeutic stem cells.
Conclusions:
- Genetically engineered stem cells represent a promising and safer platform for prostate cancer gene therapy.
- Further research is needed to fully elucidate the mechanisms and overcome the limitations of stem cell-based approaches in prostate cancer treatment.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
08:44Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells
Published on: June 22, 2013
Related Concept Videos
Gene Therapy
Gene Therapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic...